[Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. II. Membranous, membrano- proliferative and mesangial glomerulonephritis].
Klinger
M
M
Szewczyk
Z
Z
D002699:Chlorambucil / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D015432:Glomerulonephritis, Membranoproliferative / Q000188:drug therapy*; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy*; D006801:Humans; D011241:Prednisone / Q000008:administration & dosage*
D002699:Chlorambucil; D003520:Cyclophosphamide; D011241:Prednisone
Programy leczenia immunosupresyjno-przeciwzapalnego pierwotnych, idiopatycznych kłebkowych zapaleń nerek. Cześć II. Błoniaste, błoniastorozplemowe i mezangialne kłebkowe zapalenie nerek.